Cargando…
Altered Secretome and ROS Production in Olfactory Mucosa Stem Cells Derived from Friedreich’s Ataxia Patients
Friedreich’s ataxia is the most common hereditary ataxia for which there is no cure or approved treatment at present. However, therapeutic developments based on the understanding of pathological mechanisms underlying the disease have advanced considerably, with the implementation of cellular models...
Autores principales: | Pérez-Luz, Sara, Loria, Frida, Katsu-Jiménez, Yurika, Oberdoerfer, Daniel, Yang, Oscar-Li, Lim, Filip, Muñoz-Blanco, José Luis, Díaz-Nido, Javier |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555998/ https://www.ncbi.nlm.nih.gov/pubmed/32933002 http://dx.doi.org/10.3390/ijms21186662 |
Ejemplares similares
-
Future Prospects of Gene Therapy for Friedreich’s Ataxia
por: Ocana-Santero, Gabriel, et al.
Publicado: (2021) -
Friedreich's Ataxia
por: Anderson, J. Wallace
Publicado: (1893) -
The Pathology of Friedreich's Ataxia
por: Rainy, Harry
Publicado: (1905) -
Neuroinflammation in Friedreich’s Ataxia
por: Apolloni, Savina, et al.
Publicado: (2022) -
Is Friedreich ataxia an epigenetic disorder?
por: Kumari, Daman, et al.
Publicado: (2012)